Search

Your search keyword '"Azulay JP"' showing total 270 results

Search Constraints

Start Over You searched for: Author "Azulay JP" Remove constraint Author: "Azulay JP"
270 results on '"Azulay JP"'

Search Results

1. Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

2. Identification of symbol digit modality test score extremes in Huntington's disease

5. Minimal clinically important worsening on the progressive supranuclear Palsy Rating Scale

6. Suicidal ideation in a European Huntington's disease population

7. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy

8. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy

9. A combined pharmacokinetic/pharmacodynamic model of levodopa motor response and dyskinesia in Parkinson's disease patients

10. The V471A polymorphism in autophagy-related gene ATG7 modifies age at onset specifically in Italian Huntington disease patients

11. Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY

12. Placebo effect characteristics observed in a single, international, longitudinal study in Huntington's disease

13. Weight loss in Huntington disease increases with higher CAG repeat number

14. Éditorial

15. Information aux lecteurs

22. Resonance in subthalamo-cortical circuits in Parkinson's disease.

25. 18F-FDG brain PET: a metabolic predictive factor for gait improvement after cerebrospinal fluid shunting in normal pressure hydrocephalus?

26. Effects on Gait and Balance of VIM Gamma Knife Radiosurgery in Essential Tremor.

27. Molecular Imaging in CANVAS: A Contribution for Differential Diagnosis?

28. Energetic dysfunction and iron overload in early Parkinson's disease: Two distinct mechanisms?

29. ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson's disease.

30. Economic Burden of Parkinson's Disease: A Multinational, Real-World, Cost-of-Illness Study.

31. Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson's disease.

32. Orthostatic hypotension: Review and expert position statement.

33. Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.

34. A Case Report of SYNE1 Deficiency-Mimicking Mitochondrial Disease and the Value of Pangenomic Investigations.

35. Brain FDG-PET correlates of saccadic disorders in early PSP.

36. Deep Brain Stimulation-Withdrawal Syndrome in Parkinson's Disease: Risk Factors and Pathophysiological Hypotheses of a Life-Threatening Emergency.

37. [Promoting responsible self-medication in the context of Parkinson's disease: Development of a practical guide for drug-drug interactions and assessment by patients and community pharmacy professionals].

38. Trial of Prasinezumab in Early-Stage Parkinson's Disease.

39. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.

41. Validation of a non-motor fluctuations questionnaire in Parkinson's disease.

42. THN 102 for Excessive Daytime Sleepiness Associated with Parkinson's Disease: A Phase 2a Trial.

44. Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?

45. Early Parkinson's Disease Phenotypes Tailored by Personality, Behavior, and Motor Symptoms.

46. Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson's disease.

47. High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families.

48. Increased Sodium Concentration in Substantia Nigra in Early Parkinson's Disease: A Preliminary Study With Ultra-High Field (7T) MRI.

49. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.

50. Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients.

Catalog

Books, media, physical & digital resources